1. Hong Kong Stocks

  2. •

    Industrials

  3. •

    Industrial - Distribution
Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd.

PASW
Ping An Biomedical Co., Ltd.US flagNASDAQ Global Market
0.18
USD
+0.01
- -
3.23MMarket Cap
Ping An Biomedical Co., Ltd.
PASW
(NASDAQ Global Market)

Recent

price

0.18

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
FRC
7.24
5.59
4.03
- -
- -
Revenue per Share
0.38
0.35
-0.05
- -
- -
Basic EPS, GAAP
-2.28
1.03
-0.3
- -
- -
Free Cash Flow per Basic Share
- -
0.24
0.47
- -
- -
Dividend per Share
-0.15
0.22
-0.32
- -
- -
Book Value per Share
-0.15
0.22
-0.29
- -
- -
Tangible Book Value per Share
14
20
20
- -
- -
Basic Weighted Avg Shares
100
115
83
88
34
Sales/Revenue/Turnover
9.06
9.73
0.74
- -
-43.05
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
5
7
-1
-1
-13
Net Income, GAAP
33.32
24.92
2,484.34
- -
- -
Effective Tax Rate (%)
5.24
6.31
-1.2
-1.47
-37.57
Profit Margin (%)
-5
2
-9
-10
41
Working Capital
- -
- -
- -
- -
- -
LT Debt
-2
5
-6
-7
45
Total Equity
- -
34.67
-49.85
- -
- -
Return on Invested Capital (%)
- -
25.12
-111.22
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-729.39%
Free Cash Flow
- -
- -
-143.93%
Net Income, GAAP
- -
- -
899.03%
Sales/Revenue/Turnover
- -
- -
-61.03%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
83
2024
- -
- -
- -
- -
88
2025
- -
- -
- -
- -
34

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.05
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.47
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
T. Spiritual World Limited (TSPIRITUAL.BO)
OEM International AB (publ) (OEM-B.ST)
Constronics Infra Ltd. (CONSTRONIC.BO)
Diploma PLC (DPLM.L)
TX Holdings, Inc. (TXHG)
Groupe Airwell SAS (ALAIR.PA)
Business
Ping An Biomedical Co., Ltd. (NASDAQ:PASW) operates as an investment holding company that, through its subsidiaries, provides supply chain management services in the apparel industry in China; its services encompass market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company offers a broad range of yarn products, textiles, and finished garments to brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers; it also provides real estate property investment and warehousing services. Incorporated in 2021 and headquartered at China United Plaza, 22nd Floor, Cheung Sha Wan, Hong Kong, Ping An Biomedical is a subsidiary of Action Holdings Limited and employs seven people, with operations focused primarily in China. In September 2025, the company changed its name from Majestic Ideal Holdings Limited to Ping An Biomedical Co., Ltd.; in July 2025, it appointed Lina Jiang as Chief Executive Officer, succeeding prior leadership. These recent developments reflect strategic rebranding and executive enhancements amid ongoing apparel sector activities.

Company News

APIChat

  • globenewswire.com

    All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital

  • globenewswire.com

    Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

  • globenewswire.com

    Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation

  • globenewswire.com

    Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter